Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system: a study of the Swiss Group for Clinical Cancer Research (SAKK)
Titel:
Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system: a study of the Swiss Group for Clinical Cancer Research (SAKK)
Auteur:
Ghielmini, M. Rufibach, K. Salles, G. Leoncini-Franscini, L. Léger-Falandry, C. Cogliatti, S. Fey, M. Martinelli, G. Stahel, R. Lohri, A. Ketterer, N. Wernli, M. Cerny, T. Schmitz, S.-F. Hsu